// App-Quantinova.ai

OA06.04 : Constructing a Global Molecular Database for Thoracic Malignancies: The IASLC Molecular Subcommittee Lung Cancer Dataset

Researchers

Presenter

  • R. Osarogiagbon

Principal Investigators

  • K. Nishimura

  • K. Suda

  • O. Gautschi

  • K. Kerr

  • J. Matilla

  • A. Nicholson

  • H. Pass

  • R. Terra

  • I. Wistuba

  • D. Yang

  • W. Travis

  • M. Tsao

  • H. Asamura

  • D. Carbone

Medical Centers

  • Division of Thoracic Surgery, Department of Surgery, The Ohio State University Comprehensive Cancer Center, Columbus/OH/US

  • Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York

  • Brazilian National Cancer Institute, Rio de Janeiro, Brazil

  • Idisna and Program in Solid Tumors, Center for Applied Medical Research (Cima), University of Navarra, Pamplona/ES

  • Pulmonary and Critical Care Medicine, Zhongshan Hospital Fudan University, Shanghai/CN

  • University of Berne and Cantonal Hospital of Lucerne, Lucerne, Switzerland

  • Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

  • Department of Histopathology, Royal Brompton and Harefield Hospitals, London and National Heart and Lung Institute, Imperial College, London/GB

  • Department of Chemistry, New York University, New York, NY

  • Department of Urology, Yale University, New Haven, CT

  • Thoracic Surgery, Instituto Do Coracao, Hospital Das Clinicas Hcfmusp, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo/BR

  • Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama/JP

  • Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan

  • Medical Oncology, Memorial Sloan Kettering Cancer Center, New York/NY/US

  • Department of Thoracic Surgery, Hospital Universitari Mutua Terrassa, University of Barcelona, Barcelona/ES

  • Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, TN

  • Department of Pathology, Aberdeen University School of Medicine, Aberdeen/GB

  • Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH

  • Division of Thoracic Surgery, Keio University School of Medicine, Tokyo, Japan

  • Princess Margaret Cancer Center, University Health Network, Toronto/CA

  • Department of Thoracic Surgery, Hospital Clínico Universitario Valladolid, University of Valladolid, Valladolid/ES

  • Center for Thoracic Surgery, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York/NY/US

  • Cancer Research and Biostats, Seattle, WA

Locations

  • United States

  • China

  • United Kingdom

  • Brazil

  • Venezuela

  • Japan

  • Canada

  • Mexico

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Non Small Cell Lung cancer

Biomarkers

  • Anaplastic lymphoma Kinase

  • B-Raf proto-oncogene, serine/threonine kinase

  • High affinity nerve growth factor receptor

  • Proto-oncogene tyrosine-protein kinase ROS

  • Programmed death-ligand 1

  • Ret Proto-Oncogene

  • Epidermal growth factor receptor

  • erb-b2 receptor tyrosine kinase 2

  • KRAS proto-oncogene, GTPase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved